Auf dieser Seite
ROIV Roivant Sciences Ltd. - Common Shares
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 6, 2026
$35,72
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$15,2552-Wochen-Tief
$42,5052-Wochen-Hoch
Marktkapitalisierung (MRQ)
$25.81B
P/E (TTM)
-76.0
EPS (TTM)
$-0.47
Umsatz (TTM)
$8M
Ihre Abzeichen
52W-Spanne
$15–$42
Analystenbewertung
BUY
Kursziel
$48
P/E
-76.0
ROE
-6.2%
Nettogewinnmarge
-3535.0%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
ROIV Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$35.72
Marktkapitalisierung (MRQ)
$25.81B
P/E (TTM)
-76.0
EPS (TTM)
$-0.47
Umsatz (TTM)
$8M
ROE (TTM)
-6.2%
52W-Spanne
$15–$43
ROIV Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$8M2021-03-31 → 2026-03-31
EPS$-0.542022-03-31 → 2026-03-31
Freier Cashflow$-759M2022-03-31 → 2026-03-31
Nettogewinnmarge-3535.0%2022-03-31 → 2026-03-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | ROIV | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -76.05-Jahres-Durchschnitt ≈-20.1 | ≈-20.1 | · | · | |
| P/S (TTM) | 3427.25-Jahres-Durchschnitt ≈631.5 | ≈631.5 | · | · | |
| K/B (MRQ) | 6.15-Jahres-Durchschnitt ≈2.8 | ≈2.8 | 6.8 | Fairer Wert | |
| Kurs / FCF (TTM) | -31.45-Jahres-Durchschnitt ≈-11.4 | ≈-11.4 | · | · | |
| Kurs / Cashflow (TTM) | -31.65-Jahres-Durchschnitt ≈-11.6 | ≈-11.6 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 5.75-Jahres-Durchschnitt ≈3.0 | ≈3.0 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | ROIV | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -7914.8%5-Jahres-Durchschnitt ≈-2130.5% | ≈-2130.5% | -49.3% | Schwach | |
| EBITDA-Marge (TTM) | -7876.9%5-Jahres-Durchschnitt ≈-2103.0% | ≈-2103.0% | -49.3% | Schwach | |
| Vorgewinnmarge (TTM) | -3848.6%5-Jahres-Durchschnitt ≈-1162.1% | ≈-1162.1% | -42.5% | Schwach | |
| Nettogewinnmarge (TTM) | -3535.0%5-Jahres-Durchschnitt ≈-782.4% | ≈-782.4% | -43.1% | Schwach | |
| ROA (TTM) | -5.2%5-Jahres-Durchschnitt ≈1.8% | ≈1.8% | -5.4% | Im Einklang | |
| ROE (TTM) | -6.2%5-Jahres-Durchschnitt ≈-1.7% | ≈-1.7% | -9.2% | Spitzenklasse | |
| ROIC | -17.1%5-Jahres-Durchschnitt ≈-28.1% | ≈-28.1% | -17.1% | Im Einklang |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | ROIV | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 16.75-Jahres-Durchschnitt ≈19.1 | ≈19.1 | 4.5 | Starke Liquidität | |
| Quick Ratio | 15.35-Jahres-Durchschnitt ≈18.0 | ≈18.0 | 3.2 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | ROIV | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -71.6%5-Jahres-Durchschnitt ≈2.1% | ≈2.1% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -36.0%5-Jahres-Durchschnitt ≈-14.7% | ≈-14.7% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | -19.1% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | ROIV | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.05-Jahres-Durchschnitt ≈0.0 | ≈0.0 | 0.2 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$11.5K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Beat Rate
62.5%
Durchschn. Überraschung
3.2%
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 31. März 2027 | $-0.26 | $-0.34 | 22.6% | |
| 31. Dezember 2026 | Mai 20, 2026 | $-0.58 | $-0.35 | -64.6% |
| 30. Juni 2026 | $-0.26 | $-0.34 | 22.6% | |
| 31. März 2026 | $-0.32 | $-0.35 | 9.2% | |
| 31. Dezember 2025 | $-0.38 | $-0.32 | -17.3% | |
| 30. September 2025 | $-0.17 | $-0.34 | 50.1% | |
| 30. Juni 2025 | $-0.33 | $-0.32 | -4.4% | |
| 31. März 2025 | $-0.29 | $-0.31 | 7.7% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|---|
| Revenue | $8M | $29M | $33M | $32M | $55M | $24M | |
| R&D Expense | $682M | $550M | $440M | $454M | $483M | $237M | |
| SG&A Expense | $610M | $591M | $416M | $383M | $775M | $260M | |
| Operating Expenses | $1.29B | $1.14B | $884M | $938M | $1.41B | $1.09B | |
| Operating Income | $-515M | $-1.00B | $4.50B | $-907M | $-1.35B | $-1.07B | |
| Interest Expense | · | · | $35M | $28M | $7M | $3M | |
| Interest Income | $178M | $258M | $146M | · | · | · | |
| Other Non-op | $4M | $-11M | $-14M | $-486.0K | $3M | $-9M | |
| Pretax Income | $-265M | $-682M | $4.57B | $-885M | $-924M | $-899M | |
| Income Tax | $133M | $48M | $22M | $4M | $369.0K | $2M | |
| Net Income | $-300M | $-172M | $4.35B | $-1.01B | $-845M | $-809M | |
| EPS (Basic) | $-0.43 | $-0.24 | $5.55 | $-1.42 | $-1.26 | · | |
| EPS (Diluted) | $-0.54 | $-0.24 | $5.23 | $-1.42 | $-1.26 | · | |
| Shares (Basic) | 693,864,530 | 725,395,624 | 783,248,906 | 712,791,115 | 669,753,458 | · | |
| Shares (Diluted) | 693,864,530 | 725,395,624 | 831,049,444 | 712,791,115 | 669,753,458 | · | |
| EBITDA | $-512M | $-989M | $4.26B | $-1.16B | $-1.35B | · |
Bilanz
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.42B | $2.72B | $6.49B | $1.68B | $2.06B | $2.06B | |
| Short-term Investments | $2.87B | $2.17B | $0 | · | · | · | |
| Receivables | · | · | $4M | $30M | $4M | $11M | |
| Inventory | · | · | $35M | $3M | $0 | · | |
| Prepaid Expense | · | · | $34M | $61M | $53M | $40M | |
| Other Current Assets | $105M | $113M | $81M | $122M | $86M | $54M | |
| Current Assets | $5.17B | $5.00B | $6.73B | $1.80B | $2.15B | $2.19B | |
| PP&E (Net) | $12M | $12M | $15M | $39M | $26M | $15M | |
| Intangibles | · | · | $138M | $145M | $0 | · | |
| Other Non-current Assets | $41M | $33M | $38M | $49M | $26M | $27M | |
| Total Assets | $5.71B | $5.44B | $7.22B | $2.39B | $2.59B | $2.59B | |
| Accounts Payable | $18M | $24M | $14M | $38M | $35M | $21M | |
| Accrued Liabilities | $206M | $114M | $119M | $167M | $128M | $77M | |
| Short-term Debt | · | · | · | · | $0 | · | |
| Current Liabilities | $281M | $149M | $267M | $272M | $184M | $219M | |
| Capital Leases | $96M | $90M | $45M | $53M | $62M | $62M | |
| Other Non-current Liabilities | $70.0K | $22.0K | $2M | $17M | $22M | $8M | |
| Total Liabilities | $416M | $250M | $774M | $782M | $524M | $528M | |
| Long-term Debt | · | · | $431M | $376M | $210M | $170M | |
| Total Debt | · | · | $12M | $41M | $210M | · | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | |
| Paid-in Capital | $5.02B | $4.56B | $5.40B | $4.93B | $4.42B | $3.81B | |
| Retained Earnings | $-502M | $116M | $576M | $-3.77B | $-2.76B | $-1.92B | |
| AOCI | $4M | $9M | $-4M | $-3M | $-946.0K | $1M | |
| Stockholders' Equity | $4.53B | $4.69B | $5.97B | $1.16B | $1.66B | $1.80B | |
| Liabilities + Equity | $5.71B | $5.44B | $7.22B | $2.39B | $2.59B | $2.59B | |
| Shares Outstanding | 720,352,386 | 695,938,323 | 806,677,954 | 760,143,393 | 694,975,965 | 651,576,293 |
Cashflow
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|---|
| D&A | $3M | $14M | $22M | $19M | $6M | · | |
| Stock-based Comp | $346M | $289M | $200M | $218M | $565M | $85M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Other Non-cash | $-800M | $-971M | $-5.34B | $-71M | · | · | |
| Operating Cash Flow | $-750M | $-839M | $-765M | $-843M | $-678M | $-552M | |
| CapEx | $8M | $5M | $1M | $13M | $17M | $6M | |
| Investing Cash Flow | $-682M | $-1.77B | $5.20B | $-44M | $303M | $-32M | |
| Stock Issued | $0 | $0 | $200M | $312M | $0 | · | |
| Stock Repurchased | · | $1.29B | $0 | $0 | · | · | |
| Net Stock Activity | $0 | $-1.29B | $200M | $312M | · | · | |
| Financing Cash Flow | $134M | $-1.22B | $419M | $499M | $307M | $456M | |
| Net Change in Cash | $-1.29B | $-3.82B | $4.86B | $-382M | $-68M | · | |
| Taxes Paid | $48M | $62M | $12M | $5M | $916.0K | $4M | |
| Free Cash Flow | $-759M | $-844M | $-767M | $-856M | $-695M | · | |
| Levered FCF | · | · | $-801M | $-884M | $-702M | · |
Rentabilität
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -6235.7% | -3453.3% | 3399.2% | -1918.0% | -2444.8% | · | |
| Net Margin | -3629.2% | -592.0% | 3484.9% | -1646.6% | -1528.9% | · | |
| Pretax Margin | -3203.1% | -2346.0% | 3408.3% | -1998.8% | -1670.9% | · | |
| EBITDA Margin | -6195.2% | -3404.9% | 3416.9% | -1887.2% | -2444.8% | · | |
| ROA | -5.4% | -2.7% | 90.5% | -40.6% | -32.7% | · | |
| ROE | -6.5% | -3.2% | 122.0% | -71.7% | -48.9% | · | |
| ROIC | -17.1% | -22.9% | 70.6% | -98.5% | -72.4% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 18.4 | 33.5 | 25.2 | 6.6 | 11.6 | · | |
| Quick Ratio | 15.3 | 32.7 | 24.7 | 6.3 | 11.2 | · | |
| Debt / Equity | · | · | 0.0 | 0.0 | 0.1 | · | |
| LT Debt / Equity | · | · | · | · | 0.1 | · | |
| Interest Coverage | · | · | 122.0 | -42.0 | -192.0 | · |
Effizienz
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | |
| Receivables Turnover | · | · | 3.0 | 3.6 | · | · |
Pro Aktie
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.28 | $6.74 | $7.40 | $1.52 | $2.38 | · | |
| Revenue / Share | $0.01 | $0.04 | $0.15 | $0.09 | · | · | |
| Cash Flow / Share | $-1.08 | $-1.16 | $-0.92 | $-1.18 | · | · | |
| Cash / Share | $1.97 | $3.90 | $8.10 | $2.21 | $2.96 | · | |
| EPS (TTM) | $-0.54 | $-0.24 | $5.23 | $-1.42 | $-1.26 | · |
Wachstumsraten
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | -71.6% | -11.2% | 3.8% | -43.0% | 132.3% | · | |
| Revenue CAGR 3Y | -36.0% | -19.3% | 11.2% | · | · | · | |
| Revenue CAGR 5Y | -19.1% | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | $29M | $33M | $32M | $55M | · | |
| Net Income TTM | $-300M | $-172M | $4.35B | $-1.01B | $-845M | · | |
| Market Cap | $19.95B | $7.02B | $8.50B | $5.61B | $3.43B | · | |
| Enterprise Value | · | · | $1.98B | $3.97B | $1.58B | · | |
| P/E | -51.3 | -42.0 | 2.0 | -5.2 | -3.9 | · | |
| P/S | 2415.7 | 241.7 | 259.9 | 177.9 | 62.1 | · | |
| P/B | 4.4 | 1.5 | 1.4 | 4.8 | 2.1 | · | |
| P / Tangible Book | 4.4 | 1.5 | 1.5 | 5.5 | 2.1 | · | |
| P / Cash Flow | -26.6 | -8.4 | -11.1 | -6.7 | -5.1 | · | |
| P / FCF | -26.3 | -8.3 | -11.1 | -6.6 | -4.9 | · | |
| EV / EBITDA | · | · | 0.5 | -3.4 | -1.2 | · | |
| EV / FCF | · | · | -2.6 | -4.6 | -2.3 | · | |
| EV / Revenue | · | · | 60.5 | 126.0 | 28.6 | · | |
| Earnings Yield | -1.9% | -2.4% | 49.6% | -19.2% | -25.5% | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $3M | $2M | $2M | $2M | $8M | $9M | $4M | $8M | $-8M | $16M | $4M | $22M | $-2M | $17M | $13M | |
| R&D Expense | $202M | $199M | $165M | $165M | $153M | $145M | $142M | $143M | $121M | $92M | $108M | $115M | $125M | $61M | $126M | $132M | |
| SG&A Expense | $166M | $158M | $175M | $143M | $134M | $147M | $142M | $203M | $100M | $43M | $128M | $89M | $156M | $-92M | $168M | $158M | |
| Operating Expenses | $368M | $358M | $341M | $308M | $287M | $293M | $283M | $346M | $221M | $132M | $237M | $218M | $298M | $-37M | $395M | $293M | |
| Operating Income | $-366M | $415M | $-339M | $-306M | $-285M | $-285M | $-274M | $-342M | $-102M | $-140M | $5.13B | $-214M | $-276M | $34M | $-378M | $-281M | |
| Interest Expense | · | · | · | · | · | · | · | · | $13M | · | $9M | $9M | $9M | · | $8M | $8M | |
| Interest Income | $37M | $41M | $43M | $45M | $48M | $55M | $62M | $70M | · | · | · | · | · | · | · | · | |
| Other Non-op | $-2M | $13M | $8M | $-6M | $-11M | $-3M | $-3M | $-1M | $-4M | $-19M | $2M | $-2M | $5M | $-12M | $18M | $-6M | |
| Pretax Income | $-295M | $454M | $-290M | $-159M | $-269M | $-203M | $-235M | $-224M | $-20M | $-18M | $5.15B | $-241M | $-326M | $161M | $-382M | $-314M | |
| Income Tax | $-4M | $98M | $23M | $7M | $5M | $49M | $-26M | $12M | $12M | $-6M | $22M | $3M | $2M | $-5M | $3M | $2M | |
| Net Income | $-190M | $303M | $-266M | $-114M | $-223M | $-206M | $169M | $-230M | $95M | $-151M | $5.10B | $-304M | $-292M | $-34M | $-352M | $-292M | |
| EPS (Basic) | $-0.26 | $0.45 | $-0.38 | $-0.17 | $-0.33 | $-0.29 | $0.23 | $-0.31 | $0.13 | $-0.04 | $6.37 | $-0.40 | $-0.38 | $-0.03 | $-0.49 | $-0.42 | |
| EPS (Diluted) | $-0.26 | $0.34 | $-0.38 | $-0.17 | $-0.33 | $-0.28 | $0.23 | $-0.31 | $0.12 | $-0.02 | $6.03 | $-0.40 | $-0.38 | $-0.03 | $-0.49 | $-0.42 | |
| Shares (Basic) | 720,776,739 | · | 696,859,682 | 680,947,866 | 680,286,922 | · | 722,716,168 | 735,470,796 | 735,816,536 | · | 800,587,716 | 770,227,849 | 759,273,550 | · | 713,319,399 | 699,888,061 | |
| Shares (Diluted) | 720,776,739 | · | 696,859,682 | 680,947,866 | 680,286,922 | · | 722,716,168 | 735,470,796 | 781,627,601 | · | 844,461,685 | 770,227,849 | 759,273,550 | · | 713,319,399 | 699,888,061 | |
| EBITDA | $-365M | · | $-339M | $-306M | $-284M | · | $-274M | $-342M | $-115M | · | $5.06B | $-276M | $-271M | · | $-378M | $-281M |
Bilanz
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.25B | $1.42B | $1.48B | $1.24B | $1.24B | $2.72B | $1.99B | $1.96B | $5.68B | $6.49B | $6.67B | $1.41B | $1.43B | · | $1.53B | $1.60B | |
| Short-term Investments | $2.59B | $2.87B | $3.05B | $3.15B | $3.26B | $2.17B | $3.16B | $3.43B | · | $0 | · | · | · | · | · | · | |
| Receivables | · | · | · | · | · | · | $678.0K | $2M | $80M | · | $41M | $52M | $37M | · | $28M | $25M | |
| Inventory | · | · | · | · | · | · | · | · | $34M | · | $5M | $5M | $4M | · | · | · | |
| Prepaid Expense | · | · | · | · | · | · | $58M | $55M | $57M | · | $53M | $61M | $65M | · | $70M | $70M | |
| Other Current Assets | $128M | $105M | $130M | $126M | $113M | $113M | $217M | $94M | $323M | $81M | $136M | $143M | $127M | · | $119M | $112M | |
| Current Assets | $4.74B | $5.17B | $4.66B | $4.51B | $4.62B | $5.00B | $5.36B | $5.80B | $6.00B | $6.73B | $6.81B | $1.55B | $1.56B | · | $1.65B | $1.71B | |
| PP&E (Net) | $11M | $12M | $13M | $26M | $15M | $12M | $14M | $14M | $18M | $15M | $22M | $24M | $36M | · | $37M | $39M | |
| Intangibles | · | · | · | · | · | · | · | · | $136M | · | $150M | $141M | $145M | · | $146M | $140M | |
| Other Non-current Assets | $30M | $41M | $35M | $28M | $31M | $33M | $34M | $37M | $33M | $38M | $47M | $50M | $46M | · | $46M | $12M | |
| Total Assets | $5.31B | $5.71B | $5.23B | $5.06B | $5.03B | $5.44B | $5.79B | $6.21B | $6.50B | $7.22B | $7.31B | $2.07B | $2.14B | · | $2.20B | $2.22B | |
| Accounts Payable | $25M | $18M | $13M | $15M | $12M | $24M | $24M | $25M | $28M | $14M | $35M | $44M | $50M | · | $48M | $41M | |
| Accrued Liabilities | $169M | $206M | $118M | $108M | $89M | $114M | $104M | $111M | $138M | $119M | $122M | $153M | $119M | · | $132M | $129M | |
| Current Liabilities | $284M | $281M | $152M | $134M | $114M | $149M | $141M | $556M | $215M | $267M | $245M | $266M | $245M | · | $244M | $231M | |
| Capital Leases | $95M | $96M | $99M | $90M | $90M | $90M | $90M | $43M | $46M | $45M | $47M | $49M | $52M | · | $55M | $54M | |
| Other Non-current Liabilities | $6M | $70.0K | $677.0K | $170.0K | $228.0K | $22.0K | $307.0K | $295.0K | $2M | $2M | $4M | $5M | $17M | · | $21M | $9M | |
| Total Liabilities | $385M | $416M | $251M | $257M | $217M | $250M | $256M | $626M | $601M | $774M | $728M | $740M | $803M | · | $776M | $701M | |
| Long-term Debt | · | · | · | · | · | · | · | · | $312M | · | $403M | $389M | $385M | · | $375M | $376M | |
| Total Debt | · | · | · | · | · | · | · | · | $12M | · | $46M | $49M | $44M | · | $38M | $36M | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | |
| Paid-in Capital | $5.13B | $5.02B | $4.94B | $4.77B | $4.64B | $4.56B | $4.72B | $4.78B | $4.78B | $5.40B | $5.39B | $5.32B | $4.98B | · | $4.70B | $4.54B | |
| Retained Earnings | $-900M | $-502M | $-695M | $-429M | $-316M | $116M | $460M | $396M | $671M | $576M | $727M | $-4.37B | $-4.06B | · | $-3.74B | $-3.39B | |
| AOCI | $701.0K | $4M | $21M | $20M | $17M | $9M | $8M | $-18M | $-18M | $-4M | $-28M | $-3M | $-7M | · | $-729.0K | $9M | |
| Stockholders' Equity | $4.23B | $4.53B | $4.27B | $4.36B | $4.35B | $4.69B | $5.19B | $5.15B | $5.44B | $5.97B | $6.09B | $949M | $911M | · | $956M | $1.16B | |
| Liabilities + Equity | $5.31B | $5.71B | $5.23B | $5.06B | $5.03B | $5.44B | $5.79B | $6.21B | $6.50B | $7.22B | $7.31B | $2.07B | $2.14B | · | $2.20B | $2.22B | |
| Shares Outstanding | 722,668,062 | 720,352,386 | 709,689,411 | 689,697,370 | 682,229,832 | 695,938,323 | 719,632,367 | 733,328,375 | 739,053,106 | 806,677,954 | 804,890,910 | 800,792,365 | 767,137,861 | · | 726,804,831 | 704,386,981 |
Cashflow
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $600.0K | $638.0K | $691.0K | $921.0K | $1M | $1M | $3M | $5M | $5M | $5M | $5M | $6M | $6M | $6M | $5M | $5M | |
| Stock-based Comp | $83M | $77M | $105M | $82M | $82M | $83M | $84M | $72M | $50M | $47M | $54M | $49M | $49M | $25M | $58M | $62M | |
| Other Non-cash | $-165M | · | · | · | $-64M | · | · | · | $-343M | · | · | · | $-13M | · | · | · | |
| Operating Cash Flow | $-271M | $-164M | $-196M | $-186M | $-204M | $-173M | $-207M | $-267M | $-193M | $-108M | $-210M | $-196M | $-250M | $-179M | $-223M | $-190M | |
| CapEx | $419.0K | $1M | $-5M | $8M | $4M | $811.0K | $2M | $996.0K | $965.0K | $349.0K | $355.0K | $275.0K | $403.0K | $2M | $508.0K | $3M | |
| Investing Cash Flow | $281M | $173M | $109M | $120M | $-1.09B | $1.07B | $454M | $-3.29B | $-965.0K | $7M | $5.23B | $-36M | $105.0K | $114M | $-4M | $-147M | |
| Stock Issued | · | · | · | · | · | $0 | $0 | · | · | $0 | $0 | · | · | $217M | $95M | · | |
| Stock Repurchased | $207M | · | $0 | $0 | $208M | $295M | $243M | $106M | $648M | $0 | $0 | $0 | $0 | · | · | · | |
| Net Stock Activity | $-207M | · | · | · | $-208M | · | · | · | $-648M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-182M | $-69M | $328M | $63M | $-188M | $-177M | $-273M | $-109M | $-661M | $-33M | $237M | $208M | $7M | $210M | $154M | $-7M | |
| Net Change in Cash | $-170M | $-58M | $242M | $-1M | $-1.48B | $724M | $-27M | $-3.66B | $-857M | $-135M | $5.26B | $-26M | $-242M | $151M | $-72M | $-344M | |
| Free Cash Flow | $-271M | · | · | · | $-208M | · | · | · | $-194M | · | · | · | $-250M | · | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | $-205M | · | · | · | $-259M | · | · | · |
Rentabilität
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -25380.9% | · | -16966.1% | -19492.9% | -13130.0% | · | -3042.6% | -7636.0% | -218.0% | · | 13626.5% | -745.1% | -1278.3% | · | -2217.2% | -2240.2% | |
| Net Margin | -13164.8% | · | -13301.2% | -7225.9% | -10292.9% | · | 1878.2% | -5143.8% | 172.8% | · | 13721.5% | -820.3% | -1349.5% | · | -2064.4% | -2326.6% | |
| Pretax Margin | -20427.5% | · | -14525.7% | -10123.7% | -12408.4% | · | -2600.5% | -5014.1% | 127.2% | · | 13727.4% | -882.3% | -1508.0% | · | -2240.7% | -2503.4% | |
| EBITDA Margin | -25339.3% | · | -16966.1% | -19492.9% | -13079.5% | · | -3042.6% | -7636.0% | -209.1% | · | 13626.5% | -745.1% | -1251.3% | · | -2217.2% | -2240.2% | |
| ROA | -3.7% | · | -4.8% | -2.0% | -3.9% | · | 2.6% | -5.6% | 2.2% | · | 107.1% | -14.2% | -12.3% | · | -14.1% | -11.0% | |
| ROE | -4.4% | · | -5.6% | -2.4% | -4.6% | · | 3.0% | -7.5% | 3.0% | · | 144.7% | -28.9% | -25.4% | · | -24.9% | -18.2% | |
| ROIC | -8.5% | · | -8.6% | -7.3% | -6.7% | · | -4.7% | -7.0% | -1.8% | · | 82.1% | -28.0% | -29.1% | · | -38.4% | -23.6% |
Liquidität & Solvenz
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 16.7 | · | 30.7 | 33.7 | 40.5 | · | 37.9 | 10.4 | 27.9 | · | 27.8 | 5.8 | 6.4 | · | 6.7 | 7.4 | |
| Quick Ratio | 13.5 | · | 29.8 | 32.8 | 39.5 | · | 36.4 | 9.7 | 26.8 | · | 27.4 | 5.5 | 6.0 | · | 6.4 | 7.0 | |
| Debt / Equity | · | · | · | · | · | · | · | · | 0.0 | · | 0.0 | 0.1 | 0.0 | · | 0.0 | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -9.0 | · | 535.9 | -29.9 | -31.0 | · | · | · |
Effizienz
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | 0.4 | 0.2 | 0.9 | · | 1.1 | 1.0 | 1.1 | · | 0.9 | 0.7 |
Pro Aktie
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.86 | · | $6.02 | $6.33 | $6.37 | · | $7.21 | $7.03 | $7.35 | · | $7.57 | $1.18 | $1.19 | · | $1.31 | $1.65 | |
| Revenue / Share | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.01 | $0.01 | $0.07 | · | $0.04 | $0.05 | $0.03 | · | $0.02 | $0.02 | |
| Cash Flow / Share | $-0.38 | · | · | · | $-0.30 | · | · | · | $-0.25 | · | · | · | $-0.33 | · | · | · | |
| Cash / Share | $1.73 | · | $2.08 | $1.79 | $1.82 | · | $2.77 | $2.67 | $7.68 | · | $8.29 | $1.76 | $1.87 | · | $2.10 | $2.27 | |
| EPS (TTM) | $-0.47 | · | $-1.16 | $-0.55 | $-0.69 | · | $0.02 | $5.82 | $5.73 | · | $5.22 | $-1.30 | $-1.32 | · | $-1.79 | $-1.71 |
Bewertung (TTM)
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | · | $13M | $20M | $23M | · | $13M | $20M | $19M | · | $38M | $40M | $49M | · | $43M | $50M | |
| Net Income TTM | $-266M | · | $-809M | $-374M | $-491M | · | $-117M | $4.81B | $4.74B | · | $4.47B | $-982M | $-969M | · | $-1.25B | $-1.18B | |
| Market Cap | $25.58B | · | $15.40B | $10.44B | $7.69B | · | $8.51B | $8.46B | $7.81B | · | $9.04B | $9.35B | $7.73B | · | $5.81B | $2.27B | |
| Enterprise Value | · | · | · | · | · | · | · | · | $2.15B | · | $2.41B | $7.99B | $6.34B | · | $4.32B | $705M | |
| P/E | -75.3 | · | -18.7 | -27.5 | -16.3 | · | 591.5 | 2.0 | 1.8 | · | 2.2 | -9.0 | -7.6 | · | -4.5 | -1.9 | |
| P/S | 3395.5 | · | 1157.0 | 513.3 | 330.9 | · | 637.1 | 425.1 | 409.4 | · | 235.0 | 234.1 | 158.3 | · | 134.7 | 45.0 | |
| P/B | 6.0 | · | 3.6 | 2.4 | 1.8 | · | 1.6 | 1.6 | 1.4 | · | 1.5 | 9.9 | 8.5 | · | 6.1 | 2.0 | |
| P / Tangible Book | 6.0 | · | 3.6 | 2.4 | 1.8 | · | 1.6 | 1.6 | 1.5 | · | 1.5 | 11.6 | 10.1 | · | 7.2 | 2.2 | |
| P / Cash Flow | -94.5 | · | · | · | -37.6 | · | · | · | -40.5 | · | · | · | -30.9 | · | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | 112.4 | · | 62.8 | 200.1 | 129.9 | · | 100.1 | 14.0 | |
| Earnings Yield | -1.3% | · | -5.3% | -3.6% | -6.1% | · | 0.17% | 50.4% | 54.2% | · | 46.5% | -11.1% | -13.1% | · | -22.4% | -53.1% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Umsatz | $8M | $29M | $33M | $32M | $55M |
| Betriebsgewinnmarge % | -6235.7% | -3453.3% | 3399.2% | -1918.0% | -2444.8% |
| Nettoergebnis | $-300M | $-172M | $4.35B | $-1.01B | $-845M |
| Verwässerte EPS | $-0.54 | $-0.24 | $5.23 | $-1.42 | $-1.26 |
| Kennzahl | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | · | · | 0.0 | 0.0 | 0.1 |
| Liquiditätsgrad | 18.4 | 33.5 | 25.2 | 6.6 | 11.6 |
| Quick Ratio | 15.3 | 32.7 | 24.7 | 6.3 | 11.2 |
| Kennzahl | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-759M | $-844M | $-767M | $-856M | $-695M |
Institutionelle Eigentümer (13F) 534 Einreicher · $21.1B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
534
Gehaltener Wert
$21.1B
Neue Positionen
104
Geschlossene Positionen
41
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 104 (+2 vs. Vorquartal) | 41 (-3 vs. Vorquartal) | 199 (+30 vs. Vorquartal) | 145 (+9 vs. Vorquartal) | +57.7M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| FMR LLC | $2.867.311.587 | 81.020.390 | 13,56% | Aktien |
| BlackRock, Inc. | $1.707.075.250 | 48.236.091 | 8,07% | Aktien |
| MORGAN STANLEY | $1.507.362.964 | 42.592.905 | 7,13% | Aktien |
| VANGUARD GROUP INC | $912.681.190 | 42.059.041 | 4,32% | Aktien |
| QVT Financial LP | $839.559.589 | 23.723.074 | 3,97% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $782.939.977 | 22.123.198 | 3,70% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $765.886.987 | 21.641.339 | 3,62% | Aktien |
| GOLDMAN SACHS GROUP INC | $656.713.035 | 18.556.458 | 3,11% | Aktien |
| STATE STREET CORP | $629.799.555 | 17.795.975 | 2,98% | Aktien |
| UBS Group AG | $618.144.425 | 17.466.641 | 2,92% | Aktien |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $506.395.510 | 14.309.000 | 2,39% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $425.535.991 | 11.674.380 | 2,01% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $366.262.718 | 10.349.328 | 1,73% | Aktien |
| WELLS FARGO & COMPANY/MN | $339.744.000 | 9.600.000 | 1,61% | Verkaufsoption |
| Two Seas Capital LP | $299.942.849 | 8.475.356 | 1,42% | Aktien |
| Assenagon Asset Management S.A. | $295.964.871 | 8.362.952 | 1,40% | Aktien |
| PERCEPTIVE ADVISORS LLC | $286.144.465 | 8.085.461 | 1,35% | Aktien |
| Patient Square Capital LP | $283.860.642 | 8.020.928 | 1,34% | Aktien |
| Invesco Ltd. | $266.528.885 | 7.531.192 | 1,26% | Aktien |
| JANE STREET GROUP, LLC | $257.830.306 | 7.285.400 | 1,22% | Kaufoption |
| Darwin Global Management, Ltd. | $234.333.729 | 6.747.300 | 1,11% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $234.031.996 | 6.633.560 | 1,11% | Aktien |
| VIKING GLOBAL INVESTORS LP | $221.947.217 | 6.271.467 | 1,05% | Aktien |
| Rubric Capital Management LP | $212.340.000 | 6.000.000 | 1,00% | Aktien |
| CITADEL ADVISORS LLC | $197.343.877 | 5.576.261 | 0,93% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $185.062.802 | 5.230.417 | 0,88% | Aktien |
| NORGES BANK | $168.013.034 | 4.747.472 | 0,79% | Aktien |
| BAKER BROS. ADVISORS LP | $166.928.649 | 4.716.831 | 0,79% | Aktien |
| JENNISON ASSOCIATES LLC | $158.616.723 | 4.481.964 | 0,75% | Aktien |
| Point72 Asset Management, L.P. | $158.316.386 | 4.473.478 | 0,75% | Aktien |
| BANK OF AMERICA CORP /DE/ | $153.641.473 | 4.341.381 | 0,73% | Aktien |
| NORTHERN TRUST CORP | $133.142.736 | 3.762.157 | 0,63% | Aktien |
| Affinity Asset Advisors, LLC | $132.712.500 | 3.750.000 | 0,63% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $131.494.872 | 3.715.594 | 0,62% | Aktien |
| Pictet Asset Management Holding SA | $122.694.773 | 3.468.340 | 0,58% | Aktien |
| Qube Research & Technologies Ltd | $122.254.613 | 3.454.496 | 0,58% | Aktien |
| ADAR1 Capital Management, LLC | $111.726.513 | 3.157.008 | 0,53% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $105.749.602 | 2.988.121 | 0,50% | Aktien |
| D. E. Shaw & Co., Inc. | $105.203.924 | 2.972.702 | 0,50% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $102.649.863 | 2.900.533 | 0,49% | Aktien |
| MAVERICK CAPITAL LTD | $100.119.159 | 2.829.024 | 0,47% | Aktien |
| Bank of New York Mellon Corp | $98.747.526 | 2.790.266 | 0,47% | Aktien |
| NATIONAL BANK OF CANADA /FI/ | $98.168.095 | 2.773.874 | 0,46% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $95.123.719 | 2.687.870 | 0,45% | Aktien |
| Weiss Asset Management LP | $89.984.454 | 2.542.652 | 0,43% | Aktien |
| Woodline Partners LP | $88.498.817 | 2.500.673 | 0,42% | Aktien |
| JANUS HENDERSON GROUP PLC | $85.790.341 | 3.095.448 | 0,41% | Aktien |
| CITIGROUP INC | $78.749.474 | 2.225.190 | 0,37% | Aktien |
| DME Capital Management, LP | $76.182.956 | 2.152.669 | 0,36% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $73.368.318 | 2.073.137 | 0,35% | Aktien |
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Roivant Sciences Ltd. ×18 Einreichungen | 28. Februar 2020 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 16 Insider · 7 Führungskräfte · 9 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Eric Venker | President & Immunovant CEO | 30. September 2026 M | 1.599.154 | 0 | 23 | $-97.091.061 |
| Matthew Gline | CEO | 30. September 2026 F | 16.583.774 | 0 | 4 | $-46.173.010 |
| Richard Pulik | CFO | 20. September 2026 F | 269.681 | 0 | 2 | $-9.122.307 |
| Mayukh Sukhatme | President & CIO | 30. September 2026 F | 18.583.860 | 0 | 13 | $-109.133.247 |
| Frank Torti | President and Vant Chair | 30. September 2026 F | 13.495.893 | 0 | 3 | $-82.039.461 |
| Jennifer Humes | Chief Accounting Officer | 20. September 2026 F | 106.419 | 0 | 1 | $-384.073 |
| Rakhi Kumar | Chief Accounting Officer | 20. Februar 2025 F | 162.306 | 0 | 0 | $0 |
| Daniel Allen Gold | Direktor | 16. September 2026 A | 8.965.815 | 0 | 19 | $-147.382.307 |
| Melissa B, Epperly | Direktor | 16. September 2026 A | 14.954 | 0 | 5 | $-2.007.055 |
| Ilan Oren | Direktor | 16. September 2026 A | 123.680 | 0 | 0 | $0 |
| Meghan Fitzgerald | Direktor | 16. September 2026 A | 41.162 | 0 | 5 | $-3.271.652 |
| Keith S Manchester | Direktor | 16. September 2026 A | 1.753.457 | 0 | 20 | $-154.472.307 |
| James C Momtazee | Direktor | 16. September 2026 A | 111.959 | 0 | 0 | $0 |
| Andrew Lo | Direktor | 15. September 2022 A | 52.142 | 0 | 0 | $0 |
| Vivek Ramaswamy | 10%-Eigentümer | 15. Dezember 2025 M | 33.653.755 | 0 | 6 | $-105.881.464 |
| QVT Financial LP | · | 30. Juni 2026 S | 13.689.166 | 0 | 19 | $-147.382.307 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 65 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| PTH · Invesco Exchange-Traded Fund Trust | 5,09% | 511.087 SH | 1. Oktober 2026 | Täglich |
| XMMO · Invesco Exchange-Traded Fund Trust | 3,61% | 6.900.746 SH | 1. Oktober 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 1,73% | 51.097 SH | 1. Oktober 2026 | Täglich |
| IBB · iShares Trust | 1,56% | 3.945.976 SH | 11. September 2026 | Täglich |
| QQQJ · Invesco Exchange-Traded Fund Trust … | 1,33% | 426.543 SH | 1. Oktober 2026 | Täglich |
| PDP · Invesco Exchange-Traded Fund Trust | 0,83% | 333.906 SH | 1. Oktober 2026 | Täglich |
| LABU · Direxion Shares ETF Trust | 0,81% | 118.777 NS | 31. Juli 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,49% | 6.668.252 SH | 19. August 2026 | Täglich |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,48% | 258.044 SH | 19. August 2026 | Täglich |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,45% | 49.743 SH | 1. Oktober 2026 | Täglich |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,44% | 728.407 SH | 19. August 2026 | Täglich |
| IVOV · VANGUARD ADMIRAL FUNDS | 0,38% | 162.589 SH | 19. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,34% | 247.761 SH | 1. Oktober 2026 | Täglich |
| MIDU · Direxion Shares ETF Trust | 0,33% | 6.622 NS | 31. Juli 2026 | N-PORT |
| IYH · iShares Trust | 0,32% | 286.604 SH | 11. September 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,32% | 182.053 SH | 19. August 2026 | Täglich |
| SMMD · iShares Trust | 0,28% | 260.561 SH | 11. September 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,24% | 1.398.015 SH | 19. August 2026 | Täglich |
| SIZE · iShares Trust | 0,23% | 23.759 SH | 11. September 2026 | Täglich |
| EUSA · iShares, Inc. | 0,22% | 104.334 SH | 11. September 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,21% | 11.546.599 SH | 19. August 2026 | Täglich |
| MTUM · iShares Trust | 0,20% | 1.176.567 SH | 11. September 2026 | Täglich |
| IWS · iShares Trust | 0,20% | 730.954 SH | 11. September 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,18% | 5.172.729 SH | 19. August 2026 | Täglich |
| IMCV · iShares Trust | 0,17% | 49.279 SH | 11. September 2026 | Täglich |
| IWR · iShares Trust | 0,15% | 2.002.105 SH | 11. September 2026 | Täglich |
| IMCB · iShares Trust | 0,14% | 58.450 SH | 11. September 2026 | Täglich |
| IMCG · iShares Trust | 0,11% | 108.573 SH | 11. September 2026 | Täglich |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 18.431 SH | 1. Oktober 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,08% | 1.165.423 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,07% | 71.845 NS | 31. Juli 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,06% | 275.495 NS | 31. Juli 2026 | N-PORT |
| IWD · iShares Trust | 0,05% | 1.084.522 SH | 11. September 2026 | Täglich |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,05% | 295.213 SH | 19. August 2026 | Täglich |
| DFAU · Dimensional ETF Trust | 0,04% | 153.970 NS | 31. Juli 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,04% | 24.056 NS | 31. Juli 2026 | N-PORT |
| ILCV · iShares Trust | 0,04% | 11.683 SH | 11. September 2026 | Täglich |
| DFLV · Dimensional ETF Trust | 0,03% | 62.507 NS | 31. Juli 2026 | N-PORT |
| ILCB · iShares Trust | 0,03% | 9.666 SH | 11. September 2026 | Täglich |
| ESGV · VANGUARD WORLD FUND | 0,03% | 110.742 SH | 19. August 2026 | Täglich |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,03% | 90.086 SH | 1. Oktober 2026 | Täglich |
| IWB · iShares Trust | 0,03% | 337.727 SH | 11. September 2026 | Täglich |
| IUSG · iShares Trust | 0,03% | 227.241 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,03% | 134.424 SH | 11. September 2026 | Täglich |
| VOTE · TCW ETF Trust | 0,03% | 8.439 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,03% | 598.477 SH | 11. September 2026 | Täglich |
| IYY · iShares Trust | 0,03% | 18.633 SH | 11. September 2026 | Täglich |
| ILCG · iShares Trust | 0,03% | 19.200 SH | 11. September 2026 | Täglich |
| IUSV · iShares Trust | 0,03% | 168.980 SH | 11. September 2026 | Täglich |
| TOK · iShares Trust | 0,03% | 1.450 SH | 11. September 2026 | Täglich |
| URTH · iShares, Inc. | 0,02% | 46.946 SH | 11. September 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,02% | 143.748 NS | 31. Juli 2026 | N-PORT |
| ACWI · iShares Trust | 0,02% | 165.388 SH | 11. September 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,02% | 15.990.718 SH | 19. August 2026 | Täglich |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,02% | 80.578 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,02% | 41.202 SH | 19. August 2026 | Täglich |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 405.619 SH | 19. August 2026 | Täglich |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,01% | 8.472 SH | 1. Oktober 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,01% | 927 NS | 31. Juli 2026 | N-PORT |
| RWK · Invesco Exchange-Traded Fund Trust … | 0,00% | 150 SH | 23. September 2026 | Täglich |
| IJH · iShares Trust | · | 15.821.557 SH | 11. September 2026 | Täglich |
| IJK · iShares Trust | · | 1.516.631 SH | 11. September 2026 | Täglich |
| IJJ · iShares Trust | · | 965.622 SH | 21. August 2026 | Täglich |
| XJH · iShares Trust | · | 61.595 SH | 8. September 2026 | Täglich |
| SMLF · iShares Trust | · | 75.677 SH | 11. September 2026 | Täglich |
ROIV Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 19 Analysten
KAUF
Median-Ziel
$46.50
+30,2%
8 42,1%
Starker Kauf
9 47,4%
Kauf
2 10,5%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
12 Analysten · 2026-10-03Mittelwert-Ziel $48.08 +34,6%
← Unter allen Zielen
Aktueller Preis $35.72
Tief$41.00
Mittelwert$48.08
Hoch$55.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026